NYSE: PATH

Uipath Inc Stock Forecast, Predictions & Price Target

The consensus among 16 Wall Street analysts covering (NYSE: PATH) stock is to Buy PATH stock.

Out of 16 analysts, 3 (18.75%) are recommending PATH as a Strong Buy, 1 (6.25%) are recommending PATH as a Buy, 12 (75%) are recommending PATH as a Hold, 0 (0%) are recommending PATH as a Sell, and 0 (0%) are recommending PATH as a Strong Sell.

If you're new to stock investing, here's how to buy Uipath stock.

(NYSE: PATH) Uipath's forecast annual revenue growth rate of 17.86% is forecast to beat the US Software - Infrastructure industry's average forecast revenue growth rate of 10.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.64%.

Uipath's revenue in 2024 is $1,308,072,000.On average, 6 Wall Street analysts forecast PATH's revenue for 2025 to be $857,523,662,777, with the lowest PATH revenue forecast at $800,827,850,502, and the highest PATH revenue forecast at $886,407,293,955. On average, 5 Wall Street analysts forecast PATH's revenue for 2026 to be $1,041,288,447,224, with the lowest PATH revenue forecast at $1,032,779,437,933, and the highest PATH revenue forecast at $1,050,248,683,235.

In 2027, PATH is forecast to generate $1,211,785,572,875 in revenue, with the lowest revenue forecast at $1,211,785,572,875 and the highest revenue forecast at $1,211,785,572,875.

According to 16 Wall Street analysts that have issued a 1 year PATH price target, the average PATH price target is $19.13, with the highest PATH stock price forecast at $30.00 and the lowest PATH stock price forecast at $13.00.

On average, Wall Street analysts predict that Uipath's share price could reach $19.13 by May 31, 2025. The average Uipath stock price prediction forecasts a potential upside of 56% from the current PATH share price of $12.26.

(NYSE: PATH) forecast ROE is N/A, which is considered weak.